Colin Lee Novick

Mr. Novick is a cofounder and managing director of one of Japan’s leading regenerative medicine consulting firms, CJ PARTNERS. He is natively fluent in Japanese and prior to founding CJ PARTNERS in 2012 he worked as a management consultant at Deloitte Tohmatsu Consulting within the Financial Services Industry Group and at SMBC Nikko Securities, where he facilitated multiple mergers and acquisitions within the Japanese life sciences industry. Mr. Novick was selected by Dr. Yoshinori Shirono, founder of Ci:z Investment LLP, the Series C lead investor, to represent his interests on the DiscGenics Board.